Expert Review of Clinical Immunology, Volume 11, Issue sup1 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Clinical Immunology, Volume 11, Issue sup1 (2015)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Volume 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Entering a new era of biologic therapy in rheumatic diseases: development and use of biosimilar infliximab (CT-P13)

Editorial

Editorial
A scientific update on biosimilar infliximab (CT-P13) in rheumatic diseases
Peter Taylor
Pages: 1-4
Published online: 22 Sep 2015
AbstractforA scientific update on biosimilar infliximab (CT-P13) in rheumatic diseases | Full Text | References | PDF (241.7 KB)
  • 1954 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Review

Scientific rationale behind the development and approval of biosimilar infliximab (CT-P13) in Europe
Ulf Müller-Ladner, SeungSuh Hong, Choongseob Oh & Peter Taylor
Pages: 5-14
Published online: 22 Sep 2015
AbstractforScientific rationale behind the development and approval of biosimilar infliximab (CT-P13) in Europe | Full Text | References | PDF (744 KB) | Supplemental
  • 3945 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Analysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product
Dae Hyun Yoo, Choongseob Oh, SeungSuh Hong & Won Park
Pages: 15-24
Published online: 22 Sep 2015
AbstractforAnalysis of clinical trials of biosimilar infliximab (CT-P13) and comparison against historical clinical studies with the infliximab reference medicinal product | Full Text | References | PDF (440.5 KB)
  • 3220 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I study
Won Park, Sang Joon Lee, Jihye Yun & Dae Hyun Yoo
Pages: 25-31
Published online: 22 Sep 2015
AbstractforComparison of the pharmacokinetics and safety of three formulations of infliximab (CT-P13, EU-approved reference infliximab and the US-licensed reference infliximab) in healthy subjects: a randomized, double-blind, three-arm, parallel-group, single-dose, Phase I study | Full Text | References | PDF (404.4 KB)
  • 4389 Views
  • 39 CrossRef citations
  • 0Altmetric
Free Access

Review

Comparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13)
Ji Soo Kim, Sung Hwan Kim, ByoungOh Kwon & SeungSuh Hong
Pages: 33-41
Published online: 22 Sep 2015
AbstractforComparison of immunogenicity test methods used in clinical studies of infliximab and its biosimilar (CT-P13) | Full Text | References | PDF (363.9 KB)
  • 8360 Views
  • 32 CrossRef citations
  • 0Altmetric
Free Access
Biosimilars for the management of rheumatoid arthritis: economic considerations
László Gulácsi, Valentin Brodszky, Petra Baji, HoUng Kim, Su Yeon Kim, Yu Young Cho & Márta Péntek
Pages: 43-52
Published online: 22 Sep 2015
AbstractforBiosimilars for the management of rheumatoid arthritis: economic considerations | Full Text | References | PDF (570.9 KB)
  • 7779 Views
  • 76 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Immunology and targeted therapy in Castleman disease
Shinichiro Tsunoda et al.
Review Article | Published online: 27 May 2024
The effect of intense pulsed light combined with topical 0.05% cyclosporin an eyedrops in the treatment of Sjögren’s syndrome related dry eye
Yanan Huo et al.
Article | Published online: 27 May 2024
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity
Haiyang Li et al.
Article | Published online: 23 May 2024
Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease
Miguel Ángel González-Gay et al.
Review Article | Published online: 21 May 2024
View all latest articles